These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
492 related items for PubMed ID: 17003644
21. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Lee JG, Lee CY, Park IK, Kim DJ, Park SY, Kim KD, Chung KY. Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813 [Abstract] [Full Text] [Related]
24. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis. La Torre M, Cavallini M, Ramacciato G, Cosenza G, Rossi Del Monte S, Nigri G, Ferri M, Mercantini P, Ziparo V. J Surg Oncol; 2011 Nov 01; 104(6):629-33. PubMed ID: 21713779 [Abstract] [Full Text] [Related]
25. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M. Acta Oncol; 2008 Nov 01; 47(2):232-8. PubMed ID: 17924207 [Abstract] [Full Text] [Related]
27. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P, de Figueiredo RS, Leaver H, Ogston S, Kulli C, Polignano FM, Tait IS. JOP; 2012 Mar 10; 13(2):199-204. PubMed ID: 22406601 [Abstract] [Full Text] [Related]
29. Total number of resected lymph nodes predicts survival in esophageal cancer. Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M. Ann Surg; 2008 Aug 10; 248(2):221-6. PubMed ID: 18650631 [Abstract] [Full Text] [Related]
32. [Number of lymph node metastases: a significant prognostic factor for patients with radical resection of carcinoma of the ampulla of Vater]. Liu N, Liang H, Zhang RP, Pan Y, Liu Y, Deng JY, Wang XN, Ding XW, Hao XS. Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul 10; 10(4):350-2. PubMed ID: 17659460 [Abstract] [Full Text] [Related]
33. Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Mosella G. Chir Ital; 2000 Jul 10; 52(3):263-70. PubMed ID: 10932371 [Abstract] [Full Text] [Related]
34. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital. Yamaguchi K, Shimizu S, Yokohata K, Noshiro H, Chijiiwa K, Tanaka M. Hepatogastroenterology; 1999 Jul 10; 46(30):3257-62. PubMed ID: 10626197 [Abstract] [Full Text] [Related]
35. [Does the extent of lymph node dissection have an effect on morbidity and prognosis after resection of the head of the pancreas for ductal or periampullary pancreatic carcinoma?]. Böttger T, Boddin J, Küchle R, Junginger T. Langenbecks Arch Chir; 1997 Jul 10; 382(4):209-15. PubMed ID: 9445967 [Abstract] [Full Text] [Related]
36. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Hepatogastroenterology; 2006 Jul 10; 53(69):447-51. PubMed ID: 16795990 [Abstract] [Full Text] [Related]
39. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW. Arch Surg; 2005 Jun 10; 140(6):584-9; discussion 589-91. PubMed ID: 15967906 [Abstract] [Full Text] [Related]